A comparison of disproportionality analysis methods in national adverse drug reaction databases of China
- PMID: 24918197
- DOI: 10.1517/14740338.2014.915938
A comparison of disproportionality analysis methods in national adverse drug reaction databases of China
Abstract
Objective: Several disproportionality analysis methods are widely used for signal detection. The goal of this study was to compare the concordance of the performance characteristics of these methods in spontaneous reporting system of China.
Methods: Algorithms including reporting odds ratio (ROR), proportional reporting ratio (PRR) and information component (IC), a composite criterion previously used by Medicines and Healthcare Products Regulatory Agency (MHRA) were compared. Kappa coefficient was used as the gauge to test the concordance. Reports received in the year 2004 and 2005 were extracted for analysis in this study.
Results: After data processing, 361,872 reports representing 52,769 combinations were analysed. The analysis generated 24,022, 22,646, 5637 and 5302 signals of disproportionality by PRR, ROR, MHRA and IC, respectively. The kappa coefficient increased with the threshold of number of drug-adverse drug reactions (ADR) combination, and the coefficient exceeded 0.7 when the number of suspected drug-ADR exceeded 2.
Conclusion: This study shows that different measures used are broadly comparable in spontaneous reporting system in China when two or more cases per combination have been collected.
Keywords: adverse drug reaction; disproportionality analysis; pharmacovigilance; signal detection.
Similar articles
-
A comparison of measures of disproportionality for signal detection on adverse drug reaction spontaneous reporting database of Guangdong province in China.Pharmacoepidemiol Drug Saf. 2008 Jun;17(6):593-600. doi: 10.1002/pds.1601. Pharmacoepidemiol Drug Saf. 2008. PMID: 18432629
-
Exploration of statistical shrinkage parameters of disproportionality methods in spontaneous reporting system of China.Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):962-70. doi: 10.1002/pds.3811. Epub 2015 Jun 11. Pharmacoepidemiol Drug Saf. 2015. PMID: 26095121
-
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.Pharmacoepidemiol Drug Saf. 2002 Jan-Feb;11(1):3-10. doi: 10.1002/pds.668. Pharmacoepidemiol Drug Saf. 2002. PMID: 11998548
-
Quantitative signal detection using spontaneous ADR reporting.Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):427-36. doi: 10.1002/pds.1742. Pharmacoepidemiol Drug Saf. 2009. PMID: 19358225 Review.
-
Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?Clin Drug Investig. 2017 May;37(5):415-422. doi: 10.1007/s40261-017-0503-6. Clin Drug Investig. 2017. PMID: 28224371 Review.
Cited by
-
Cardiotoxicity Induced by Immune Checkpoint Inhibitors: A Pharmacovigilance Study From 2014 to 2019 Based on FAERS.Front Pharmacol. 2021 Feb 12;12:616505. doi: 10.3389/fphar.2021.616505. eCollection 2021. Front Pharmacol. 2021. PMID: 33643048 Free PMC article.
-
Cardiovascular toxicity profiles of immune checkpoint inhibitors with or without angiogenesis inhibitors: a real-world pharmacovigilance analysis based on the FAERS database from 2014 to 2022.Front Immunol. 2023 May 24;14:1127128. doi: 10.3389/fimmu.2023.1127128. eCollection 2023. Front Immunol. 2023. PMID: 37292205 Free PMC article.
-
Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data.Front Endocrinol (Lausanne). 2022 Dec 13;13:1032199. doi: 10.3389/fendo.2022.1032199. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36583004 Free PMC article.
-
Allograft rejection following immune checkpoint inhibitors in solid organ transplant recipients: A safety analysis from a literature review and a pharmacovigilance system.Cancer Med. 2023 Mar;12(5):5181-5194. doi: 10.1002/cam4.5394. Epub 2022 Dec 12. Cancer Med. 2023. PMID: 36504294 Free PMC article. Review.
-
Risk of bronchospasm and coronary arteriospasm with sugammadex use: a post marketing analysis.Ther Adv Drug Saf. 2019 Aug 18;10:2042098619869077. doi: 10.1177/2042098619869077. eCollection 2019. Ther Adv Drug Saf. 2019. PMID: 31452867 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials